Table 5.
Analysis of Variance
| Variable | Univariate | Multivariate | ||||||
|---|---|---|---|---|---|---|---|---|
| Median | 95% Confidence Interval | P | HR | 95% Confidence Interval | P | |||
| Lower bound | Upper bound | Lower bound | Upper bound | |||||
| Clinical stage | ||||||||
| IIIB | 29.47 | 19.871 | 39.07 | 0.029 | 1.226 | 0.431 | 3.125 | 0.670 |
| IV | 11.565 | 8.191 | 14.938 | |||||
| ECOG | ||||||||
| 1 | 16.427 | 9.619 | 23.235 | 0.004 | 1.968 | 1.050 | 3.688 | 0.035 |
| 2 y 3 | 8.476 | 2.836 | 14.117 | |||||
| Albumin (gr/dL) | ||||||||
| ≤ 3.5 | 6.669 | 1.982 | 11.357 | < 0.0001 | 0.33 | 0.180 | 0.604 | < 0.0001 |
| > 3.5 | 29.47 | 21.016 | 37.924 | |||||
| Neutrophils (thousands/mm3) | ||||||||
| ≤ 6.25 | 22.177 | 10.132 | 34.221 | 0.033 | 1.397 | 0.800 | 2.440 | 0.240 |
| > 6.25 | 11.532 | 4.306 | 18.757 | |||||
| PMN-MDSCs (%) | ||||||||
| ≤ 8 | 22.045 | 4.335 | 39.735 | 0.039 | 1.926 | 1.088 | 3.408 | 0.024 |
| > 8 | 9.265 | 0.00 | 18.81 | |||||
Statistically significant are in bold
HR Hazard ratio